title: Coordinate expression of fimbriae in uropathogenic Escherichia coli.
abstract: Uropathogenic Escherichia coli is the most common etiological agent of urinary tract infections. Bacteria can often express multiple adhesins during infection in order to favor attachment to specific niches within the urinary tract. We have recently demonstrated that type 1 fimbria, a phase-variable virulence factor involved in adherence, was the most highly expressed adhesin during urinary tract infection. Here, we examine whether the expression of type 1 fimbriae can affect the expression of other adhesins. Type 1 fimbrial phase-locked mutants of E. coli strain CFT073, which harbors genes for numerous adhesins, were employed in this study. CFT073-specific DNA microarray analysis of these strains demonstrates that the expression of type 1 fimbriae coordinately affects the expression of P fimbriae in an inverse manner. This represents evidence for direct communication between genes relating to pathogenesis, perhaps to aid the sequential occupation of different urinary tract tissues. While the role of type 1 fimbriae during infection has been clear, the role of P fimbriae must be further defined to assert the relevance of coordinated regulation in vivo. Therefore, we examined the ability of P fimbrial isogenic mutants, constructed in a type 1 fimbrial-negative background, to compete in the murine urinary tract over a period of 168 h. No differences in the colonization of these mutants were observed. However, comparison of these results with previous studies suggests that inversely coordinated expression of adhesin gene clusters does occur in vivo. Interestingly, the mutant that was incapable of expressing either type 1 or P fimbriae compensated by synthesizing F1C fimbriae.
authors.affiliation: Department of Microbiology and Immunology, University of Michigan Medical School, 5641 Medical Science Building II, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Snyder
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Haugen
authors.forename: C Virginia
authors.initials: CV
authors.lastname: Lockatell
authors.forename: Nathalie
authors.initials: N
authors.lastname: Maroncle
authors.forename: Erin C
authors.initials: EC
authors.lastname: Hagan
authors.forename: David E
authors.initials: DE
authors.lastname: Johnson
authors.forename: Rodney A
authors.initials: RA
authors.lastname: Welch
authors.forename: Harry L T
authors.initials: HL
authors.lastname: Mobley
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000235:genetics* / Q000378:metabolism* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000382:microbiology; D029968:Escherichia coli Proteins / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D036781:Fimbriae Proteins / Q000096:biosynthesis* / Q000235:genetics; D010861:Fimbriae, Bacterial / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D005838:Genotype; D051379:Mice; D008808:Mice, Inbred CBA; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis; D014552:Urinary Tract Infections / Q000382:microbiology
chemical_list: D029968:Escherichia coli Proteins; D036781:Fimbriae Proteins